CX Institutional lifted its stake in shares of Lam Research Co. (NASDAQ:LRCX – Free Report) by 959.4% during the 4th quarter, HoldingsChannel reports. The firm owned 28,731 shares of the semiconductor company’s stock after acquiring an additional 26,019 shares during the period. CX Institutional’s holdings in Lam Research were worth $2,075,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in the stock. Van ECK Associates Corp boosted its stake in shares of Lam Research by 1,394.7% during the third quarter. Van ECK Associates Corp now owns 16,081,071 shares of the semiconductor company’s stock valued at $13,123,440,000 after purchasing an additional 15,005,178 shares in the last quarter. Assenagon Asset Management S.A. acquired a new stake in Lam Research during the 4th quarter worth approximately $175,652,000. Janney Montgomery Scott LLC acquired a new stake in Lam Research during the 4th quarter worth approximately $35,253,000. Guinness Asset Management LTD increased its position in Lam Research by 1,129.8% in the 4th quarter. Guinness Asset Management LTD now owns 482,156 shares of the semiconductor company’s stock valued at $34,825,000 after acquiring an additional 442,949 shares during the period. Finally, ARS Investment Partners LLC raised its stake in shares of Lam Research by 908.9% during the fourth quarter. ARS Investment Partners LLC now owns 490,881 shares of the semiconductor company’s stock valued at $35,456,000 after acquiring an additional 442,224 shares during the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Lam Research Price Performance
LRCX stock opened at $79.68 on Friday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 1.74. The company’s 50-day moving average is $75.24 and its 200-day moving average is $80.07. The stock has a market capitalization of $102.52 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.53 and a beta of 1.45. Lam Research Co. has a 1 year low of $68.87 and a 1 year high of $113.00.
Lam Research Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 8th. Investors of record on Wednesday, December 11th were given a $0.23 dividend. This represents a $0.92 annualized dividend and a yield of 1.15%. The ex-dividend date was Wednesday, December 11th. Lam Research’s payout ratio is currently 29.74%.
Analyst Ratings Changes
Several analysts recently weighed in on LRCX shares. Mizuho reduced their price objective on shares of Lam Research from $95.00 to $90.00 and set an “outperform” rating on the stock in a research note on Friday, January 10th. KeyCorp raised Lam Research from a “sector weight” rating to an “overweight” rating and set a $95.00 price target for the company in a research note on Friday, January 17th. Cantor Fitzgerald restated a “neutral” rating and set a $100.00 price objective on shares of Lam Research in a research report on Thursday, October 24th. StockNews.com cut Lam Research from a “buy” rating to a “hold” rating in a report on Friday, October 11th. Finally, Wolfe Research lowered shares of Lam Research from an “outperform” rating to a “peer perform” rating in a report on Wednesday, January 15th. Nine analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and an average price target of $95.77.
Check Out Our Latest Report on LRCX
About Lam Research
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also
- Five stocks we like better than Lam Research
- What Do S&P 500 Stocks Tell Investors About the Market?
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Invest in Small Cap StocksĀ
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Despite Short-Term Risks Freeport McMoran Worth a Look
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.